France, April 22 -- One year after its launch, the FRATHEA radiotherapy project (Flash RAdiation THerapy Electron Acceleration), supported by Institut Curie in collaboration with the CEA, is taking a major new step: Thales has been selected as a partner in charge of building and installing a very high energy electron irradiator (VHEE) on the Orsay site of Institut Curie. This project aims to increase the recovery rate in cancer patients and reduce the side effects induced by radiation thanks to the combination of FLASH radiotherapy with very high energy electron beams.This partnership will make it possible to have a unique, world-leading platform by 2029 to demonstrate the effectiveness and safety of FLASH-VHEE radiotherapy, and launch the ...